Coronavirus basic research service
Since December 2019, multiple cases of pneumonia with unknown etiology have been found in Wuhan, China for the first time. The World Health Organization (WHO) eventually terms the pneumonia as Coronavirus Disease 2019 (COVID-19), and the novel coronavirus causing the outbreak is named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by International Committee on Taxonomy of Viruses (ICTV). COVID-19 has spread to all provinces in China and many other countries. As a leading supplier in the field of biopharmaceuticals, Creative Biostructure has established an advanced COVID-19 discovery platform with our expertise in structural biology, which can provide a wide range of contract research services involved in structure-based basic research, antiviral drug discovery, and vaccine development to help combat SARS-CoV-2 outbreak.